1. Home
  2. IMRX vs HBIO Comparison

IMRX vs HBIO Comparison

Compare IMRX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • HBIO
  • Stock Information
  • Founded
  • IMRX 2008
  • HBIO 1901
  • Country
  • IMRX United States
  • HBIO United States
  • Employees
  • IMRX N/A
  • HBIO N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IMRX Health Care
  • HBIO Industrials
  • Exchange
  • IMRX Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • IMRX 62.7M
  • HBIO 61.2M
  • IPO Year
  • IMRX 2021
  • HBIO 2000
  • Fundamental
  • Price
  • IMRX $1.76
  • HBIO $0.99
  • Analyst Decision
  • IMRX Buy
  • HBIO
  • Analyst Count
  • IMRX 7
  • HBIO 0
  • Target Price
  • IMRX $12.20
  • HBIO N/A
  • AVG Volume (30 Days)
  • IMRX 319.9K
  • HBIO 284.5K
  • Earning Date
  • IMRX 03-04-2025
  • HBIO 03-06-2025
  • Dividend Yield
  • IMRX N/A
  • HBIO N/A
  • EPS Growth
  • IMRX N/A
  • HBIO N/A
  • EPS
  • IMRX N/A
  • HBIO N/A
  • Revenue
  • IMRX N/A
  • HBIO $97,732,000.00
  • Revenue This Year
  • IMRX N/A
  • HBIO N/A
  • Revenue Next Year
  • IMRX N/A
  • HBIO $4.32
  • P/E Ratio
  • IMRX N/A
  • HBIO N/A
  • Revenue Growth
  • IMRX N/A
  • HBIO N/A
  • 52 Week Low
  • IMRX $1.00
  • HBIO $0.94
  • 52 Week High
  • IMRX $7.68
  • HBIO $4.70
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 40.02
  • HBIO 16.00
  • Support Level
  • IMRX $1.70
  • HBIO $1.26
  • Resistance Level
  • IMRX $1.92
  • HBIO $1.43
  • Average True Range (ATR)
  • IMRX 0.09
  • HBIO 0.10
  • MACD
  • IMRX -0.01
  • HBIO -0.03
  • Stochastic Oscillator
  • IMRX 15.00
  • HBIO 6.05

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

Share on Social Networks: